Financials
- Market Capitalization 1.9 B
- Employee 835
- Founded 1980
- CEO Douglas S. Ingram
- Website www.sarepta.com
- Headquarter Delaware, United States
- FIGI BBG000BCJ161
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-22.67
市销率
1.08
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2012 | SION Sionna Therapeutics, Inc. - Common Stock | 42.59 USD | -3.09% | -4.25% | +18.27% | +8.26% | 1.92 B USD | ||
| 2025 | URGN UroGen Pharma Ltd. - Ordinary Shares | 39.19 USD | -0.81% | +4.87% | +27.86% | +106.26% | 1.91 B USD | ||
| 2040 | NTLA Intellia Therapeutics, Inc. - Common Stock | 13.30 USD | +2.15% | -20.88% | -9.95% | -3.06% | 1.86 B USD | ||
| 2046 | BCAX Bicara Therapeutics Inc. - Common Stock | 28.10 USD | -0.18% | -6.05% | +30.58% | +94.60% | 1.85 B USD |